Literature DB >> 10649821

Management of hyperprolactinemia in infertility.

P G Crosignani1.   

Abstract

Hyperprolactinemia is a frequent cause of anovulatory sterility, although spontaneous pregnancy may occur occasionally. Dopaminergic treatment is highly effective for both idiopathic and tumoral hyperprolactinemia. If the only cause of infertility is chronic anovulation due to hyperprolactinemia, a 60-80% pregnancy rate can be achieved. These results mean that surgical treatment is still needed only rarely. Either spontaneous or drug-induced pregnancy is usually uneventful for the mother and is not associated with any increase in abortion, twins or malformations. Pregnancy-related tumor growth occurs rarely and can be treated successfully with dopaminergic drugs. Pregnancy frequently leads to some improvement in the biochemical and clinical disorders associated with hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10649821

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  1 in total

1.  Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs.

Authors:  Chan Woo Kang; Ye Eon Han; Mi Kyung Lee; Yoon Hee Cho; NaNa Kang; JaeHyung Koo; Cheol Ryong Ku; Eun Jig Lee
Journal:  Exp Mol Med       Date:  2018-04-06       Impact factor: 8.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.